297 related articles for article (PubMed ID: 24196788)
1. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.
Zeestraten EC; Reimers MS; Saadatmand S; Goossens-Beumer IJ; Dekker JW; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jan; 110(2):459-68. PubMed ID: 24196788
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study.
Reimers MS; Engels CC; Putter H; Morreau H; Liefers GJ; van de Velde CJ; Kuppen PJ
BMC Cancer; 2014 Jul; 14():486. PubMed ID: 24997850
[TBL] [Abstract][Full Text] [Related]
3. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
Engels CC; Charehbili A; van de Velde CJ; Bastiaannet E; Sajet A; Putter H; van Vliet EA; van Vlierberghe RL; Smit VT; Bartlett JM; Seynaeve C; Liefers GJ; Kuppen PJ
Breast Cancer Res Treat; 2015 Feb; 149(3):587-96. PubMed ID: 25616355
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma.
Vangangelt KMH; van Pelt GW; Engels CC; Putter H; Liefers GJ; Smit VTHBM; Tollenaar RAEM; Kuppen PJK; Mesker WE
Breast Cancer Res Treat; 2018 Apr; 168(3):601-612. PubMed ID: 29273955
[TBL] [Abstract][Full Text] [Related]
5. An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer.
Bennedsen ALB; Cai L; Hasselager RP; Özcan AA; Mohamed KB; Eriksen JO; Eiholm S; Bzorek M; Fiehn AK; Hviid TVF; Gögenur I
BMC Cancer; 2022 Jan; 22(1):62. PubMed ID: 35027037
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients.
Guo ZY; Lv YG; Wang L; Shi SJ; Yang F; Zheng GX; Wen WH; Yang AG
Cell Immunol; 2015 Jan; 293(1):10-6. PubMed ID: 25461612
[TBL] [Abstract][Full Text] [Related]
7. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of HLA class I and II antigens in colon cancer.
McDougall CJ; Ngoi SS; Goldman IS; Godwin T; Felix J; DeCosse JJ; Rigas B
Cancer Res; 1990 Dec; 50(24):8023-7. PubMed ID: 2123744
[TBL] [Abstract][Full Text] [Related]
9. HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma.
Boujelbene N; Ben Yahia H; Babay W; Gadria S; Zemni I; Azaiez H; Dhouioui S; Zidi N; Mchiri R; Mrad K; Ouzari HI; Charfi L; Zidi I
HLA; 2019 Jul; 94(1):11-24. PubMed ID: 30907063
[TBL] [Abstract][Full Text] [Related]
10. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
[TBL] [Abstract][Full Text] [Related]
13. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray.
Reimers MS; Zeestraten EC; van Alphen TC; Dekker JW; Putter H; Saadatmand S; Liefers GJ; van de Velde CJ; Kuppen PJ
Int J Colorectal Dis; 2014 Sep; 29(9):1043-52. PubMed ID: 24950792
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci.
Arvind P; Papavassiliou ED; Tsioulias GJ; Duceman BW; Lovelace CI; Geng W; Staiano-Coico L; Rigas B
Mol Immunol; 1994 Jun; 31(8):607-14. PubMed ID: 8196671
[TBL] [Abstract][Full Text] [Related]
17. The effect of ethanol on the expression of HLA class I genes in human colon adenocarcinoma cell lines.
Papavassiliou ED; Arvind P; Tsioulias GJ; Qiao L; Goldin E; Staiano-Coico L; Rigas B
Cancer Lett; 1994 Jun; 81(1):33-8. PubMed ID: 8019985
[TBL] [Abstract][Full Text] [Related]
18. HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
Garziera M; Bidoli E; Cecchin E; Mini E; Nobili S; Lonardi S; Buonadonna A; Errante D; Pella N; D'Andrea M; De Marchi F; De Paoli A; Zanusso C; De Mattia E; Tassi R; Toffoli G
PLoS One; 2015; 10(12):e0144000. PubMed ID: 26633805
[TBL] [Abstract][Full Text] [Related]
19. HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma.
Jesionek-Kupnicka D; Bojo M; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Jabłońska J; Kalinka-Warzocha E; Kordek R; Młynarski W; Robak T; Warzocha K; Lech-Maranda E
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):225-40. PubMed ID: 26667793
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
